# Amneal Pharmaceuticals, Inc.: Form 8-K/A, filed Nov 12, 2024

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K/A
- Filed: 2024-11-12
- Accepted by EDGAR: Nov 12, 2024, 16:25 ET
- Period: 2024-11-08
- Accession: 0001723128-24-000044
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000172312824000044/amrx-20241108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000172312824000044/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000172312824000044/amrx-20241108.htm

Filed Nov 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001723128-24-000044. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
